FLC
NKGNW

Fifth Lane Capital’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Fifth Lane Capital’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,920
Closed -$2K – 267
2022
Q2 		$2K Sell
7,920
-2,300
-23% -$911 ﹤0.01% 324
2022
Q1 		$5K Hold
10,220
– – ﹤0.01% 299
2021
Q4 		$12K Buy
+10,220
New +$10.4K 0.01% 271

Other funds holding NKGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Fifth Lane Capital's NKGNW Position: Q3 2022 in Review

Fifth Lane Capital sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q3 2022, closing a stake of 7,920 shares — an estimated $2K sold.

Fifth Lane Capital first reported a position in NKGNW in Q4 2021 and held it in 3 quarters. The position peaked at $12K in Q4 2021. 32 funds tracked by Wall St. Rank hold NKGNW as of Q3 2022.

  • Fifth Lane Capital reported no remaining NKGen Biotech, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
  • Fifth Lane Capital sold 7,920 NKGen Biotech, Inc. Warrants shares in Q3 2022, an estimated $2K.
  • Fifth Lane Capital first reported a position in NKGen Biotech, Inc. Warrants in Q4 2021 and held it in 3 quarters.
  • Fifth Lane Capital's NKGen Biotech, Inc. Warrants position peaked at $12K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q3 2022.

Based on Fifth Lane Capital's 13F filing for Q3 2022, filed 14 Nov 2022.